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Abstract 
Anticoagulant compounds are likely to play an important role in the control of commensal rodents for 
crop protection and conservation for the foreseeable future. However there are concerns regarding their 
persistence and the development of more widespread resistance. We are seeking to retrieve and retain 
older alternatives and develop novel rodenticides. Our three pronged approach is firstly to improve the 
performance of older non-anticoagulant rodenticides such as zinc phosphide, secondly to optimise the 
performance of 1st generation anticoagulants and thirdly to identify alternatives to anticoagulant 
rodenticides with the same mode of action as paraminopropiophenone (PAPP), which was registered in 
New Zealand as a predacide in April 2011. 
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Introduction 
The most prolific period of rodenticide development occurred between the 1940s and the 1980s. First 
generation anticoagulant rodenticides and zinc phosphide were developed in the 1940s, 50s and 60s, with 
cholecalciferol, bromethalin and second generation anticoagulant rodenticides developed in the 1970’s 
and 80’s, partly to overcome resistance to the less potent anticoagulants (Buckle and Smith, 1994). 
During this period it was recognised that it was important to have two classes of rodenticides, both 
anticoagulants and alternatives to anticoagulants. In recent times the need for toxicants for field use that 
are effective but less persistent than second-generation anticoagulants, and therefore likely to be less 
hazardous to non-target bird species and other non-target species has been highlighted. Ironically 
registration requirements in Europe and around the world have reduced the number of options available 
for rodent management. We believe it is important to retain and refine the use of rodent control tools for 
conservation, disease control and agricultural protection and develop new alternatives to anticoagulants. 
Ideally alternatives to existing anticoagulants would combine limited persistence and humaneness, 
however this is a significant challenge. A microencapsulated form of zinc phosphide has been developed 
and a low dose of cholecalciferol combined with diphacinone or coumatetralyl is being re-evaluated 
(Eason et al., 2010a) to provide three low residue alternatives. In April 2011 para aminopropiophenone 
(PAPP), a methaemoglobinaemia inducer was registered for the control of predators in New Zealand. 
PAPP is humane in its mode of action and does not bioaccummulate. It has an antidote and is highly 
toxic to species like stoats (Eason et al., 2010b) but unfortunately not toxic to rodents. Approximately 50 
compounds with the same mode of action including analogues of PAPP have recently been screened to 
assess their potency as rodenticides. 
Methods 
Groups of caged rats have been presented with a microencapsulated form of zinc phosphide containing 
1.5% in a palatable paste bait. Coumatetralyl (0.03%) combined with cholecalciferol (0.015%) and 
diphacinone (0.05%) also combined with cholecalciferol (0.015% and 0.03%) have been tested on caged 
rats in the same bait matrix. Analogues of PAPP have been screened for their potency as rodenticides. In 
vitro work was carried out using a methaemoglobin assay involving hepatic microsomes and rat 
erythrocytes. The toxicity of the most promising candidates from the in-vitro screening has recently been 
assessed in vivo in laboratory rats by oral gavage.  
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Results 
A microencapsulated form of zinc phosphide containing 1.5% has been shown to be 100% effective in 
caged rats. A combination of coumatetralyl (0.03%) and cholecalciferol (0.015%) has also been 
confirmed as having high potency in rats and similar to that achieved by diphacinone (0.05%) and 
cholecalciferol (0.15%). Diphacinone (0.05%) was partially effective as a single dose rodenticide when 
combined with cholecalciferol (0.015%) and more effective when combined with a higher dose of 
cholecalciferol (0.03%). PAPP and sodium nitrite have been developed as vertebrate pesticides in New 
Zealand and Australia (Eason et al., 2010b). In laboratory rats neither compound is sufficiently potent to 
be an effective rodenticide. Approximately 50 compounds with the same mode of action including 
analogues of PAPP have been screened for their potency as rodenticides. This screening has identified a 
compound with an LD50 of approximately 40-50mg/kg. Further derivatives of this more potent analogue 
are being synthesized and screened.  
Conclusion 
It has been suggested that product innovation needs to be stimulated to encourage alternatives to the 
current suite of rodenticides, as a number of these are associated with secondary poisoning or 
bioaccumulation or they are viewed as inhumane (Mason and Littin, 2003). We have advanced an 
improved formulation of zinc phosphide and are confirming the synergistic effects of cholecalciferol 
when co-administered with first generation anticoagulants. These developments may provide partial 
solutions and help provide products that break the cycle of rodenticide resistance. However to produce 
completely new rodenticides a new level of innovation is needed. Our current approach is to attempt to 
build on the platform created by PAPP. We are part way through a programme of research, development 
and registration activity and further in vitro and in-vivo testing is scheduled over the next 3 years on 
novel candidates as well as field trials. Any new tools that emerge would most likely need to be 
integrated with anticoagulant rodenticides which are likely to play an important role in the control of 
rodents for the foreseeable future. 
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